Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.1751 per EA under NDC 16729036615. Its NADAC has been published 292 times since Oct 21, 2020.
The Low Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEStrength
12.5; 20 mg/1; mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729036615
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA209281On Market Since
9/21/2020
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 292 times since Oct 21, 2020, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1751 per EA |
|---|---|
| All-time high | $0.4784 (Nov 11, 2020) |
| All-time low | $0.1502 (Nov 20, 2024) |
| 52-week high | $0.1999 |
| 52-week low | $0.1669 |
| Median price | $0.2043 |
| Average price | $0.2169 |
| Largest weekly change | -40.2% (Nov 18, 2020) |
| Weeks tracked | 292 |
| Tracking since | Oct 21, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Accord Healthcare Inc., is $0.1751 per EA (NDC 16729036615), effective May 20, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 63.4%. It has been tracked across 292 weekly CMS publications since Oct 21, 2020.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Oct 21, 2020, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1502 (Nov 20, 2024) to a high of $0.4784 (Nov 11, 2020), with a median of $0.2043 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 16729036615) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification